Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT02452008 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02452008
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-03
- Primary completion
- 2025-12-08
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.